PG

Prashant Gujar

Active Director Director DIN 10196485
DIN 10196485 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Prashant Gujar

Data last updated:

Prashant Gujar is a Director at Nuera Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Nuera Pharmaceuticals Private Limited reported revenue of ₹31.2 Lakh (FY 2025).

DIN 10196485
Primary Designation Director
Industry Pharma
First Appointment 10 Jun 2023
Oldest Company Age 12 yrs
Largest company Nuera Pharmaceuticals Private Limited · ₹31.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jun 20232014₹31.2 Lakh (FY 2025)Active

Board colleagues of Prashant Gujar

NameDINCompanyDesignation
Himanshu Joshi10196484Nuera Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nuera Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prashant Gujar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prashant Gujar

Prashant Gujar currently holds 1 directorship: Nuera Pharmaceuticals Private Limited (Director, since 10 Jun 2023, revenue ₹31.2 Lakh (FY 2025)).

Prashant Gujar was first appointed on 10 Jun 2023 as Director at Nuera Pharmaceuticals Private Limited.

The current boards of Prashant Gujar's companies include Himanshu Joshi (Nuera Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available